July 19, 2012
1:12-cv-00965
28:1332 Diversity - Stockholders Suits
News Coverage, Answers, Appeals, Complaints, Motions, Orders, Trial Notes
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Human Genome Sciences Inc. on Thursday beat back two shareholder challenges to its $3 billion takeover by GlaxoSmithKline PLC, securing rejections of motions seeking to delay the close of the tender offer, which expires Friday.